Home Medicine Rapid detection of non-deletional mutations causing α-thalassemia by multicolor melting curve analysis
Article
Licensed
Unlicensed Requires Authentication

Rapid detection of non-deletional mutations causing α-thalassemia by multicolor melting curve analysis

  • Qiuying Huang , Xudong Wang , Ning Tang , Chunjiang Zhu , Tizhen Yan , Ping Chen EMAIL logo and Qingge Li EMAIL logo
Published/Copyright: August 22, 2015

Abstract

Background:α-Thalassemia, caused by mutations in the α-globin genes, is one of the most common monogenic inherited disorders in the world. However, non-deletional α-thalassemia mutations remain undetected in routine clinical testing due to the lack of a suitable method. In this study, a closed- and single-tube assay for the detection of six common non-deletional α-thalassemia mutations in the HBA2 gene was developed based on multicolor melting curve analysis.

Methods: The assay consisted of one pair of primers specific for the HBA2 gene and four dual-labeled, self-quenched probes targeting six non-deletional α-thalassemia mutations. The sensitivity, reproducibility, and accuracy of the method were validated via 700 genomic DNA samples.

Results: The assay had a reproducibility of 100%, could detect gDNA of different genotype as low as 1 ng per reaction, and had an overall accuracy of 100% when compared with RDB analysis and Sanger sequencing.

Conclusions: The developed assay is rapid, robust, and cost-effective while maintaining high sensitivity, specificity, and throughput.


Corresponding authors: Ping Chen, Guangxi Key Laboratory of Thalassemia Research, Guangxi Zhuang Autonomous Region, Nanning 530021, P.R. China, E-mail: ; and Hemoglobin Laboratory, the First Affiliated Hospital of Guangxi Medical University, Guangxi Key Laboratory of Thalassemia Research, Guangxi Zhuang Autonomous Region, Nanning, P.R. China; and Qingge Li, Engineering Research Center of Molecular Diagnostics, Ministry of Education, School of Life Sciences, Xiamen University, Xiamen 361005, Fujian, P.R. China, E-mail: ; and State Key Laboratory of Cellular Stress Biology, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Engineering Research Centre of Molecular Diagnostics, Ministry of Education, School of Life Sciences, Xiamen University, Xiamen, Fujian, P.R. China
aQiuying Huang and Xudong Wang contributed equally to this work.

Acknowledgments

We thank Dr. Ineke Rood for critical reading of the manuscript.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: This research work was supported by the National Natural Science Foundation of China (Grant No. 81101323), Guangxi Key Laboratory Project (Grant No. 12-071-05), Guangxi Scientific Research and Technology Development Project (Grant No. 1298003-4-1), and Liuzhou Scientific Research and Technology Development Projects (Grant No. 2014G020404).

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests:The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis 2010;5:13.10.1186/1750-1172-5-13Search in Google Scholar PubMed PubMed Central

2. Liu YN, Li R, Zhou JY, Xie XM, Li J, Liao C, et al. Screening for mutations in the alpha-globin genes leading to abnormal hemoglobin variants with high resolution melting analysis. Clin Chem Lab Med 2011;50:273–7.Search in Google Scholar

3. Guida V, Colosimo A, Fiorito M, Foglietta E, Bianco I, Ivaldi G, et al. Denaturing HPLC-based assay for molecular screening of non-deletional mutations causing alpha-thalassemias. Clin Chem 2004;50:1242–5.10.1373/clinchem.2004.032664Search in Google Scholar PubMed

4. Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood 2003;101:791–800.10.1182/blood-2002-07-1975Search in Google Scholar PubMed

5. Wang W, Ma ES, Chan AY, Chui DH, Chong SS. Multiple minisequencing screen for seven southeast Asian nondeletional alpha-thalassemia mutations. Clin Chem 2003;49:800–3.10.1373/49.5.800Search in Google Scholar PubMed

6. Eng B, Patterson M, Walker L, Chui DH, Waye JS. Detection of severe non-deletional alpha-thalassemia mutations using a single-tube multiplex ARMS assay. Genet Test 2001;5:327–9.10.1089/109065701753617471Search in Google Scholar PubMed

7. Sura T, Trachoo O, Viprakasit V, Vathesatogkit P, Tunteeratum A, Busabaratana M, et al. Hemoglobin H disease induced by the common SEA deletion and the rare hemoglobin Quong Sze in a Thai female: longitudinal clinical course, molecular characterization, and development of a PCR/RFLP-based detection method. Ann Hematol 2007;86:659–63.10.1007/s00277-007-0303-9Search in Google Scholar PubMed

8. Yang Y, Li DZ. Detection of uncommon deletions in alpha-thalassemia using the pcr-reverse dot-blot method for prenatal diagnosis of nondeletional hemoglobin H disease. Acta Haematol 2010;124:9–12.10.1159/000315300Search in Google Scholar PubMed

9. Chan V, Yam I, Chen FE, Chan TK. A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br J Haematol 1999;104:513–5.10.1046/j.1365-2141.1999.01221.xSearch in Google Scholar PubMed

10. Lacerra G, Fiorito M, Musollino G, Di Noce F, Esposito M, Nigro V, et al. Sequence variations of the alpha-globin genes: scanning of high CG content genes with DHPLC and DG-DGGE. Hum Mutat 2004;24:338–49.10.1002/humu.20088Search in Google Scholar PubMed

11. Haywood A, Dreau H, Timbs A, Schuh A, Old J, Henderson S. Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing. Ann Hematol 2010;89:1215–21.10.1007/s00277-010-1013-2Search in Google Scholar PubMed

12. Shih HC, Er TK, Chang TJ, Chang YS, Liu TC, Chang JG. Development of a high-resolution melting method for the detection of hemoglobin alpha variants. Clin Biochem 2010;43:671–6.10.1016/j.clinbiochem.2010.01.011Search in Google Scholar PubMed

13. Li R, Liao C, Li D, Li J. High-resolution melting analysis of the three common nondeletional alpha-thalassemia mutations in the Chinese population: Hbs Constant Spring, Quong Sze and Westmead. Hemoglobin 2010;34:587–93.10.3109/03630269.2010.526881Search in Google Scholar PubMed

14. Huang Q, Liu Z, Liao Y, Chen X, Zhang Y, Li Q. Multiplex fluorescence melting curve analysis for mutation detection with dual-labeled, self-quenched probes. PLoS One 2011;6:e19206.10.1371/journal.pone.0019206Search in Google Scholar PubMed PubMed Central

15. Xiong F, Huang Q, Chen X, Zhou Y, Zhang X, Cai R, et al. A melting curve analysis-based PCR assay for one-step genotyping of beta-thalassemia mutations a multicenter validation. J Mol Diagn 2011;13:427–35.10.1016/j.jmoldx.2011.03.005Search in Google Scholar PubMed PubMed Central

16. Hu S, Li G, Li H, Liu X, Niu J, Quan S, et al. Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis. J Clin Microbiol 2014;52:1644–52.10.1128/JCM.03395-13Search in Google Scholar PubMed PubMed Central


Supplemental Material:

The online version of this article (DOI: 10.1515/cclm-2015-0173) offers supplementary material, available to authorized users.


Received: 2015-2-19
Accepted: 2015-7-22
Published Online: 2015-8-22
Published in Print: 2016-3-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. The way of prostate cancer diagnostics
  4. Review
  5. Statistical methods used in the calculation of geriatric reference intervals: a systematic review
  6. Opinion Paper
  7. The side effects of translational omics: overtesting, overdiagnosis, overtreatment
  8. Genetics and Molecular Diagnostics
  9. Rapid detection of non-deletional mutations causing α-thalassemia by multicolor melting curve analysis
  10. General Clinical Chemistry and Laboratory Medicine
  11. Patient pools and the use of “patient means” are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay
  12. Long-term stability of glucose: 96-h study using Terumo Glycaemia tubes
  13. Glucose is stable during prolonged storage in un-centrifuged Greiner tubes with liquid citrate buffer, but not in serum and NaF/KOx tubes
  14. Croatian laboratories have a good knowledge of the proper detection and management of hemolyzed, icteric and lipemic samples
  15. Fetal exposure to ethanol: relationship between ethyl glucuronide in maternal hair during pregnancy and ethyl glucuronide in neonatal meconium
  16. Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood
  17. Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study
  18. Comparison of functional fibrinogen (FF/CFF) and FIBTEM in surgical patients – a retrospective study
  19. Reference Values and Biological Variations
  20. Assessment of serum free light chain levels in healthy adults immediately after marathon running
  21. Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients
  22. Cancer Diagnostics
  23. An epidemiology-based model as a tool to monitor the outbreak of inappropriateness in tumor marker requests: a national scale study
  24. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes
  25. Infectious Diseases
  26. Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma
  27. Evaluating the use of procalcitonin in an asymptomatic, HIV-infected antiretroviral therapy-naïve, South African cohort
  28. Diabetes
  29. Early prediction of gestational diabetes: a practical model combining clinical and biochemical markers
  30. Letters to the Editors
  31. Highly-trained dogs’ olfactory system for detecting biochemical recurrence following radical prostatectomy
  32. More on the accuracy of the Architect enzymatic assay for hemoglobin A1c and its traceability to the IFCC reference system
  33. Assessing quality from an accuracy-based HbA1c proficiency survey
  34. HbG-Honolulu interferes with some cation-exchange HPLC HbA1c assays
  35. Between analyser differences in chloride measurements and thus anion gap cause different interpretations of the acid-base balance
  36. Non-albumininuric proteinuria: a urinary tubular marker in the diagnosis of diabetic kidney disease
  37. International Normalized Ratio (INR) testing: analytical and clinical performance of four point-of-care devices versus central laboratory instrumentation analysis
  38. Genetic screening of the makorin ring finger 3 gene in girls with idiopathic central precocious puberty
  39. Practical approach for medical validation of therapeutic drug monitoring results
  40. Marked elevation of procalcitonin in a patient with a drug related infusion reaction to rituximab
Downloaded on 23.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0173/pdf
Scroll to top button